Ortho-hydroxybenzoic Acid (i.e., Salicyclic Acid) Or Derivative Doai Patents (Class 514/159)
  • Patent number: 11896691
    Abstract: A universal mineral based sunscreen that is good for all skin colors and prevents any ashy visual appearance on all colors of skin.
    Type: Grant
    Filed: January 9, 2023
    Date of Patent: February 13, 2024
    Inventors: Julius Zecchino, Marina Turso
  • Patent number: 11891374
    Abstract: Embodiments of the present invention generally concern pharmaceutical formulations and compositions and methods for using the pharmaceutical formulations and compositions which comprise derivatives of benzimidazole compounds, their racemic mixtures, their enantiomers, their complexes, their salts, and combinations thereof which have been found to be novel agonists of imidizoline receptors with surprising life extending efficacies due to their geroprotective (anti-geriatric) actions on pathologies associated with the aging processes in humans and animals.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: February 6, 2024
    Inventors: Boris Farber, Artur Viktorovich Martynov, Serhii Ivanovych Merzlikin
  • Patent number: 11890605
    Abstract: A monolithic metal-organic framework (MOF) composite body is disclosed, comprising: MOF crystallites adhered to each other via a binder comprising MOF; and at least 0.15 vol % nanoparticles encapsulated in the MOF body. The nanoparticles have an average particle size corresponding to an average particle diameter in the range 3-200 nm. The nanoparticles may have photocatalytic activity. The MOF composite body is of use for treating water containing an organic dye, the photocatalytic reaction supported by the photocatalytic nanoparticles being a degradation reaction of the organic dye.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: February 6, 2024
    Assignee: Cambridge Enterprise Limitd
    Inventors: David Fairen-Jimenez, Tian Tian, Joshua Mehta, Andrew Wheatley, Bethany Connolly
  • Patent number: 11872711
    Abstract: The invention relates to a lubricating member for a razor cartridge having a lubricating member comprising a carboxymethyl cellulose.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: January 16, 2024
    Assignee: The Gillette Company LLC
    Inventors: Alison Fiona Stephens, Joia Kirin Spooner-Fleming
  • Patent number: 11865210
    Abstract: The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: January 9, 2024
    Assignee: VECTURA INC.
    Inventor: Kambiz Yadidi
  • Patent number: 11851462
    Abstract: Testing peptides in in vitro models of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Frontotemporal dementia, Amyotrophic lateral sclerosis, to evaluate systems and methods of treatment therefore.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: December 26, 2023
    Assignee: University of South Carolina
    Inventors: Amar N. Kar, Pabitra Sahoo, Jeffery Twiss, Sean McGill
  • Patent number: 11826342
    Abstract: A cannabinoid formulation includes a cannabinoid composition, an anti-inflammatory ingredient, an additive, and a delivery vehicle. The cannabinoid composition is in the amount of 0.1% to 15% of the final concentration of the formulation. The anti-inflammatory ingredient is in the amount of 10% to 30% of the final concentration of the formulation. The additive is in the amount of 1% to 5% of the final concentration of the formulation. The cannabinoid formulation is designed to be administrated topically to a target area on a human.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: November 28, 2023
    Inventor: Saaransh Mahna
  • Patent number: 11779017
    Abstract: The present invention relates to an antimicrobial composition and more particularly to an antimicrobial composition at the pH of skin. The present invention provides an antimicrobial composition comprising: a. 0.5 to 20% by weight of a solvent comprising an alkyl glycol ether, b. 0.1 to 20% by weight of a carboxylic acid selected from an aromatic carboxylic acid having pKa greater than 4 or an aliphatic carboxylic acid having pKa greater than 4.5 or mixtures thereof c. 1 to 80% by weight of an anionic surfactant.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: October 10, 2023
    Assignee: CONOPCO, INC.
    Inventors: Sameer Keshav Barne, Maya Treesa Saji
  • Patent number: 11771708
    Abstract: Disclosed herein are novel drug carriers including a non-aqueous pH dependent release system and a non-aqueous pH dependent reassembly/assembly and reabsorption/absorption system. The carriers are capable of pH dependent release of biologically active agents and assembly or reassembly when the carrier transitions from a low pH environment, to a high pH environment and back to a low pH environment.
    Type: Grant
    Filed: February 18, 2022
    Date of Patent: October 3, 2023
    Assignee: Greenwood Brands, LLC
    Inventors: Ronald R. Zimmerman, Efthymios Deliargyris, Robert W. Strozier, Jeffrey W. Moore
  • Patent number: 11660276
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: May 30, 2023
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Wilson Caparros-Wanderley, Gregory Alan Stoloff, Suzanne Jane Dilly, Gemma Szucs, Olga Pleguezuelos Mateo
  • Patent number: 11648316
    Abstract: The present invention relates to an oral pharmaceutical composition containing pemetrexed as a water-soluble anticancer drug and a method of manufacturing the same, and more particularly to an oral pharmaceutical composition, in which an ion-binding complex of pemetrexed and a bile acid derivative as an oral absorption enhancer is formed, mixed with a pharmaceutical additive, and then provided in the form of a capsule or a tablet through pressing or included in the internal water phase of a w/o/w (water-in-oil-in-water) multiple nanoemulsion, thus increasing the oral bioavailability of pemetrexed as the water-soluble anticancer drug, whereby pemetrexed, which is currently administered only in the form of an injection formulation, can be manufactured into a formulation capable of being orally administered, ultimately alleviating inconvenience and problems with use of injection formulations, improving patient compliance and contributing to a reduction in medical expenses.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: May 16, 2023
    Assignee: ICURE BNP CO., LTD.
    Inventors: Jin Woo Park, Young Ro Byun, Young Kweon Choi, Kwan Young Chang, Jae Bum Lee
  • Patent number: 11642324
    Abstract: The present disclosure relates to pharmaceutical compositions of tranexamic acid and methods of using the compositions. The pharmaceutical compositions of the present disclosure are stable and suitable for topical application.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: May 9, 2023
    Assignee: Bio 54, LLC
    Inventors: Bushra Agha, Douglas Edward Schoelzel
  • Patent number: 11510928
    Abstract: There is described herein the use of mirtazapine in methods for the treatment of inflammatory disorders, autoimmune disease, and PBC.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: November 29, 2022
    Assignee: UTI Limited Partnership
    Inventors: Mark G. Swain, Abdel Aziz Shaheen, Wagdi Almishri, Gilaad G. Kaplan
  • Patent number: 11504384
    Abstract: A pharmaceutical composition for treating skin infections is described herein. A method using a pharmaceutical composition for treating skin infections is described herein. A pharmaceutical composition for treating skin infections may comprise, in 100 parts of the composition, 1-99 parts of a pharmaceutically acceptable excipient; 99-1 parts of a keratolytic; 99-1 parts ethyl pyruvate; and 99-1 parts povidone iodine. A method for treating skin infections may comprise topical application of a composition to an infected skin cell for a treatment period.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: November 22, 2022
    Assignee: Pedicis Research LLC
    Inventors: Robert Alonso, Lawrence Stoll
  • Patent number: 11401326
    Abstract: Embodiments of the disclosure relate to the use of an IL-17 pathway inhibitor for treating chronic infections caused by one or more HPVs.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: August 2, 2022
    Assignees: Assistance Publique—Hopitaus De Paris, Universite Paris Diderot—Paris 7
    Inventors: Vincent Descamps, Florence Brunet-Possenti
  • Patent number: 11389382
    Abstract: A biphasic leave-on skin peel composition, being light-weight, with a pleasing feel upon application, with little to no skin irritation and discomfort. The composition includes at least one of each of alpha and beta hydroxy acids and high content of non-water miscible oil and is present from at least 20% by weight based on the total weight of the composition. The oily and water phases may be present in equal amounts (about 1:1). The composition includes water and alcohol as solvents in the water phase and may include phenylethyl resorcinol and other optional additives, may be devoid or essentially free of surfactant.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: July 19, 2022
    Assignee: L'OREAL
    Inventors: Rebecca Chen, Seung Ook Yang, Anne-Laure Suzanne Bernard
  • Patent number: 11351150
    Abstract: Compositions for treating a sleep disorder or modifying or improving the sleep-wake cycle in a subject are disclosed herein. In some examples, the composition can comprise one or more sleep promoting active agents, one or more sleep quality active agents, one or more sleep recovery active agents, and optionally one or more next day active agents. The composition can provide an immediate burst release of the one or more sleep promoting active agents, a delayed burst or delayed sustained release of the one or more sleep quality active agents, a delayed burst or delayed sustained release of the one or more sleep recovery active agents, and a delayed burst or delayed sustained release of the one or more next day active agents. The composition can be provided as a daily oral uni-dosage form. Methods of making and using the compositions are also provided.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: June 7, 2022
    Assignee: NightWise, LLC
    Inventors: Danny Rinaldi, Scott Forsberg
  • Patent number: 11337995
    Abstract: A analgesic composition for topical application is provided that includes magnesium sulfate and a source of vitamin B12 in an amount effective for providing pain relief associated with peripheral neuropathy. The composition has a viscosity effective for allowing topical application of the composition to an afflicted area where the magnesium sulfate and vitamin B12 is absorbed through the dermis to the subcutaneous to provide pain relief relating to symptoms of peripheral neuropathy. The composition provides the novel benefits of being portable, easily dispensed, and provides a higher concentration of applied magnesium sulfate and vitamin B12 than the traditional dispensing method of Epsom Salt soaking solutions.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: May 24, 2022
    Assignee: Epsom-It, Inc.
    Inventor: Matthew Zoeller
  • Patent number: 11154500
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: May 25, 2020
    Date of Patent: October 26, 2021
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 10966945
    Abstract: This patent pertains to selective inhibition of assembly of the membrane attack complex of complement by use of less than 1 kDa molecular weight forms of the aurin tricarboxylic acid synthetic complex (ATAC), and their derivatives. It further pertains to the use of these materials to treat human conditions where there is evidence of self destruction of host tissue by the membrane attack complex. These diseases include, but are not limited to, Alzheimer disease, age related macular degeneration, and atherosclerosis.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: April 6, 2021
    Assignee: Aurin Biotech Inc.
    Inventors: Patrick L. McGeer, Moonhee Lee, Jian-Ping Guo, Claudia Schwab
  • Patent number: 10849869
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: December 1, 2020
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Wilson Caparros-Wanderley, Gregory Alan Stoloff, Suzanne Jane Dilly, Gemma Szucs, Olga Pleguezuelos Mateo
  • Patent number: 10835490
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: November 17, 2020
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 10828308
    Abstract: Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering from type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: November 10, 2020
    Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
    Inventors: Yaron Ilan, Doina Cosma Roman, Michael Hayden, Einat Amit-Romach
  • Patent number: 10667937
    Abstract: The magnetorheological (MAR) medical brace includes a flexible outer shell that fits around the anatomical area to be braced and a plurality of adjustable straps for securing the shell onto the anatomical area. The shell encases a MAR pack filled with magnetorheological fluid or gel. A plurality of magnets is attached to or encased in the shell to provide magnetic field acting on the MAR pack. The interaction of the magnetic field with the MAR pack adjustably increases or decreases the stiffness of the shell depending on the strength of the magnetic field. A control mechanism is provided for selective adjustment of the magnetic field and other functions.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: June 2, 2020
    Inventors: Clifford T. Solomon, Theodore C. Solomon
  • Patent number: 10653778
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 19, 2020
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Patent number: 10570161
    Abstract: A new family of therapeutics which provides a controlled-release delivery platform for non-steroidal anti-inflammatory agents on an ester or an ester-carbonate backbone is disclosed herein. These agents are reversible inhibitors of acetylcholinesterase and are thus useful for clinical conditions benefiting from inflammation suppression and cholinergic intervention. These compounds are of the general formula wherein n=0, 1; X=C, Si, and N+ and NSAID=ibuprofen, naproxen, indomethacin and diclofenac. Other embodiments are also disclosed.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: February 25, 2020
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, LEHIGH UNIVERSITY
    Inventors: Jeffrey D. Laskin, Diane E. Heck, Mou-Tuan Huang, Karine Fabio, Carl J. Lacey, Sherri C. Young, Pramod Mohanta, Christophe Guillon, Ned D. Heindel
  • Patent number: 10505993
    Abstract: An apparatus and method is provided for healing and regeneration of live human and animal bodies and influencing interaction and intercommunication at the cellular level. The apparatus can include one or more environmental and/or body sensors. An electrical circuit can also be provided to produce a square or trapezoidal wave that is delivered to a transducer for application, preferably timed at specific frequencies Delta, Theta, Alpha, to Beta, based on information received from the one or more sensors. In certain embodiments, a DC power source can be provided which allows the apparatus to be portable. A wireless communication module can also be provided.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: December 10, 2019
    Assignee: BLUGREEN TECHNOLOGIES, INC.
    Inventors: Iulius Dutu, Razvan Dutu
  • Patent number: 10493019
    Abstract: A new natural oil personal care composition and system for treating damaged hair and/or supporting healthy hair and healthy hair growth. The composition comprises a blend of natural oils including Jamaican black castor oil, and one or more of natural sweet almond oil (preferably unrefined), pure avocado oil, and hemp seed oil (preferably unrefined). The oils are preferably organic. The composition is useful for repairing damaged, depleted and/or thinning hair due to various factors, including inadequate nutrition or overproduction of sebum, which can result in hair loss. The composition is also useful for repairing dry, frizzy, oily, dull (low shine), and brittle hair that has been naturally damaged by the elements (e.g. the sun, heat, wind, and/or cold), by wearing head gear or hair accessories that create friction with the hair surface (e.g. helmets, hair elastics and hair bands), by inappropriate or overuse use of hair styling tools (e.g.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: December 3, 2019
    Assignee: May 11, LLC
    Inventor: Romina Manenti
  • Patent number: 10450260
    Abstract: This disclosure relates to compounds containing both an NO-releasing moiety and an H2S-releasing moiety and the use of such compounds in treating inflammatory diseases, including cancers.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: October 22, 2019
    Assignee: Research Foundation of The City University of New York
    Inventors: Khosrow Kashfi, Ravinder Kodela
  • Patent number: 10426748
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: October 1, 2019
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Wilson Caparros-Wanderley, Gregory Alan Stoloff, Suzanne Jane Dilly, Gemma Szucs, Olga Pleguezuelos Mateo
  • Patent number: 10426969
    Abstract: A magnetic coil system featuring a multi-layer structure, a spherical shape, or both allows for efficient generation of a gradient magnetic field that induces an electric field in air in a region proximate to the coil. By subjecting at least a portion of a person's brain to the induced electric field various psychiatric disorders can be treated.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: October 1, 2019
    Assignee: The McLean Hospital Corporation
    Inventor: Michael Rohan
  • Patent number: 10413583
    Abstract: Synthetic probes for detecting the activity of enzymes that catalyze reactions of post-translationally modified cysteine residues are described. The probes include “turn-on” probes that include a carbamate linkage that is cleaved via an intramolecular reaction with a free thiol produced by an enzyme catalyzed activity. The probes also include ratiometric, Michael addition-based probes that respond to enzymatic activity by a change in structure that results in a change in fluorescence properties. Methods of using the probes to detect enzymatic activity and disease are described. For example, the probes can be used to detect enzymatic activity in a variety of samples, including live cells and heterogeneous tissues. In addition, prodrugs that can be activated by enzymes that catalyze reactions of post-translationally modified cysteine residues and methods of using the prodrugs to treat disease are described.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: September 17, 2019
    Assignee: The University of Chicago
    Inventors: Bryan C. Dickinson, Rahul S. Kathayat, Michael W. Beck
  • Patent number: 10300294
    Abstract: It is an aspect of the present invention to provide a method for recording a response to Transcranial Magnetic Stimulation (TMS) utilizing a bi-phasic double pulse pair from a TMS coil device to stimulate a subject wherein the second pulse has a lower amplitude compared to the first pulse in the bi-phasic double pulse pair. Significant advantages are achieved using bi-phasic double pulse pairs, particularly where the second pulse in a pair has an intensity lower than the first. Obtaining measurements is simpler and more accurate as the number and intensity of stimulation can be reduced compared to standard single pulse stimulation.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: May 28, 2019
    Assignee: Nexstim Oyj
    Inventors: Tuomas Neuvonen, Henri Hannula, Gustaf Jarnefelt, Jarmo Laine
  • Patent number: 10279191
    Abstract: A system for treating neurological conditions by low-frequency time varying electrical stimulation includes an electrical device for applying such low-frequency energy, in a range below approximately 10 Hz, to the patient's brain tissue. An implantable embodiment applies direct electrical stimulation to electrodes implanted in or on the patient's brain, while a non-invasive embodiment causes a magnetic field to induce electrical currents in the patient's brain.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: May 7, 2019
    Assignee: NeuroPace, Inc.
    Inventors: David R. Fischell, Adrian R. M. Upton
  • Patent number: 10231943
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a cardiovascular disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: March 19, 2019
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Suzanne Jane Dilly, Gregory Alan Stoloff, Wilson Caparros Wanderley
  • Patent number: 10231995
    Abstract: The use of selenite- or selenate-containing preparations supplemented with pharmaceutically acceptable or food-compatible acids for the preparation of an agent intended for topical or buccal application or mucosal administration is described.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: March 19, 2019
    Assignee: SELO MEDICAL GMBH
    Inventors: Bodo Kuklinski, Peter Kössler, Norbert Fuchs
  • Patent number: 10213381
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: February 26, 2019
    Assignee: infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 10172847
    Abstract: A method for reducing, inhibiting, and eliminating inflammation and pain by using an effective amount of iron chelator composition to balance oxidative activity at a cutaneous site of inflammation and pain. The composition contained in transdermal formulations and administered topically in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: January 8, 2019
    Inventor: Kenneth Russell
  • Patent number: 10155042
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: December 18, 2018
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Patent number: 10004704
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: June 26, 2018
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Wilson Caparros-Wanderley, Gregory Alan Stoloff, Suzanne Jane Dilly, Gemma Szucs, Olga Pleguezuelos Mateo
  • Patent number: 9987215
    Abstract: The present invention relates to process for preparing cosmetic compositions at two stages. The first relates to the preparation of organogels in which liquid oils are structured by a mixture of structuring agents such as monoglycerides and waxes, which also have the addition of other components such as polymers and polyol esters. The second step is the formation of the cold or hot process cosmetic compositions where emulsions are prepared by the addition of water, aqueous solutions and other components, to the organogel. The emulsions prepared have superior sensory, chemical-physical and stability characteristics, to those currently produced by the classic technology of preparation with emulsifiers.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: June 5, 2018
    Assignee: CHEMYUNION QUIMICA LTDA.
    Inventors: Cecilia Nogueira, Cristiane Rodrigues da Silva Pacheco, Daniel Barrera Arellano, Daniele Cristina Zulim Botega, Mario Luiz Mathias Netto
  • Patent number: 9901638
    Abstract: A combination of antibiotics including rifabutin, clarithromycin and clofazimine for the treatment of an autoimmune disease such as multiple sclerosis and related diseases. In a further aspect, there is provided a composition comprising a combination of two or more antibiotic agents for the treatment of an autoimmune disease, said two or more antibiotic agents selected from rifabutin, clofazimine, and at least one macrolide.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: February 27, 2018
    Assignee: RedHill Biopharma Ltd.
    Inventors: Reza Fathi, Patrick Laughlin McLean, Harry Jefferson Leighton
  • Patent number: 9827215
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: November 28, 2017
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 9820952
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: November 21, 2017
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 9789075
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a cardiovascular disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: October 17, 2017
    Assignee: Infirst Helathcare Limited
    Inventors: Robin Mark Bannister, John Brew, Suzanne Jane Dilly, Gregory Alan Stoloff, Wilson Caparros-Wanderley
  • Patent number: 9750810
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: September 5, 2017
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Patent number: 9744132
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: August 29, 2017
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
  • Patent number: 9737698
    Abstract: A method and system for treating patients with Alzheimer disease includes steps and equipment operative for subjecting a patient suffering from Alzheimer disease to a non-invasive action directed toward a patient's brain and causing a cavitation process in the patient's brain liquid in the vicinity of lesions and thereby destroying the latter.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: August 22, 2017
    Inventors: Mikhail Topchiashvili, Luba Chigirinskay, Marika Cherfas
  • Patent number: 9717667
    Abstract: An oral care composition is provided wherein the composition comprises an ionic liquid, wherein the ionic liquid comprises: a) a quaternary ammonium cation of the formula wherein R1, R2, R3 and R4 are each an organic moiety and may be the same or different, and at least one of R1, R2, R3 and R4 includes a hydroxyl; and b) an anion selected from the group consisting of salicylate, alkylsulfate, sulfate, acetate, halide, phosphate, alkyl phosphate and tosylate; wherein the oral care composition is a mouth rinse, toothpaste, toothpowder, oral bead or strip, fluid-encased dental strip, irrigation fluid, plaque removal liquid, dental floss, hard candy, soft candy, lozenge, chewing gum, or lollipop.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: August 1, 2017
    Assignee: Colgate-Palmolive Company
    Inventors: Madhusudan Patel, Guillaume Picquet, Mark Vandeven, Mahmoud Hassan, Rosa Paredes
  • Patent number: 9693980
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: July 4, 2017
    Assignee: Infirst Healthcare Limited
    Inventors: Robin Mark Bannister, John Brew, Wilson Caparros-Wanderley, Gregory Alan Stoloff, Suzanne Jane Dilly, Gemma Szucs, Olga Pleguezuelos Mateo